Majority of Top Government Science Jobs Unfilled

Only 12 positions out of 44 have received nominations, and half of Trump’s nominees have strong ties to the industries they would oversee, a new report shows.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, ATHERTONCUSTOMSNearly three-quarters of top federal science positions remain without nominations, and more than half of US President Donald Trump’s nominees have potentially problematic ties to the industries they would regulate, according to a new analysis from The Center for Investigative Reporting published in Reveal News yesterday (August 30). The analysis follows months of inaction on the appointment of scientific officials that have left many federal agencies without leadership roles.

“Even the external advisory bodies have really ground to a halt,” Andrew Rosenberg, director of The Center for Science and Democracy at the advocacy nonprofit Union of Concerned Scientists, tells Reveal. “The philosophy of this administration is that the most important thing we can do is deregulate.”

Of the 44 top federal science positions, 32 remain without any nominees at all. Of the nominated 12, only two have been appointed, and a further eight are awaiting a vote in the US Senate. In the meantime, federal agencies in charge of the nation’s science programs and billions of dollars in research spending are lacking oversight.

“Staff can only go so far before they hit these empty seats,” Cristin Dorgelo, chief of staff in the White House ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies